Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Karra

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
AAPS Pharmscitech|January 20, 2004
Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101MG Krishna, W F Hodnick, W Lang, et al.
Oncogene|July 21, 2001
Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combinationJ Hu, X Ma, D J Lindner, et al.
Oncogene|July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combinationX Ma, S Karra, D J Lindner, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Biochemistry|March 8, 2016
Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide BindingAndrea C McReynolds, Aroon S Karra, Yan Li, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 7, 2016
Understanding hydraulic fracturing: a multi-scale problemJ D Hyman, J Jiménez-Martínez, H S Viswanathan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
AAPS Pharmscitech|January 20, 2004
Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101MG Krishna, W F Hodnick, W Lang, et al.
Oncogene|July 21, 2001
Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combinationJ Hu, X Ma, D J Lindner, et al.
Oncogene|July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combinationX Ma, S Karra, D J Lindner, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Biochemistry|March 8, 2016
Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide BindingAndrea C McReynolds, Aroon S Karra, Yan Li, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 7, 2016
Understanding hydraulic fracturing: a multi-scale problemJ D Hyman, J Jiménez-Martínez, H S Viswanathan, et al.
Pageof 2